Synthetic Chemical Trade as a Potential Driver of Global Health Disparities and Data Gaps on Synthetic Chemicals in Vulnerable Populations

Goodman, Dina; Arisco, Nicholas J.; Jaacks, Lindsay M.

doi:10.1007/s40572-020-00261-w

Cited by 7 publications

(2 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to WHO, the global burden of disease attributed to chemical exposure is 45 million DALYs [ 26 ]. There are specific populations which need additional protection due to increased physiological vulnerability to chemical exposure and which lack capacity for advocacy and representation [ 27 ]. Most notable among this group are pregnant women and their fetuses, infants and children, the elderly, people residing in areas of low-socioeconomic status (LSES) including some Aboriginal and Torres Strait Islanders populations, and those in occupations with greater chemical exposure.…”

Section: Risks To Human Health From Chemical Exposure Particularly Fo...mentioning

confidence: 99%

Strengthening Australia’s Chemical Regulation

Gabriela

Leong

Ong

et al. 2022

IJERPH

View full text Add to dashboard Cite

Humans are exposed to a myriad of chemicals every day, some of which have been established to have deleterious effects on human health. Regulatory frameworks play a vital role in safeguarding human health through the management of chemicals and their risks. For this review, we focused on agricultural and veterinary (Agvet) chemicals and industrial chemicals, which are regulated, respectively, by the Australian Pesticides and Veterinary Medicines Authority (APVMA), and the Australian Industrial Chemicals Introduction Scheme (AICIS). The current frameworks have been considered fragmented, inefficient, and most importantly, unsafe in prioritizing human health. We evaluated these frameworks, identified gaps, and suggested improvements that would help bring chemical regulation in Australia in line with comparative regulations in the EU, US, and Canada. Several weaknesses in the Australian frameworks include the lack of a national program to monitor chemical residues, slow pace in conducting chemical reviews, inconsistent risk management across states and territories, a paucity of research efforts on human health impacts, and inadequate framework assessment systems. Recommendations for Australia include establishing a national surveillance and chemical residue monitoring system, harmonizing risk assessment and management across jurisdictions, improving chemical review efficiency, and developing regular performance review mechanisms to ensure that human health is protected.

show abstract

Section: Risks To Human Health From Chemical Exposure Particularly Fo...mentioning

confidence: 99%

Strengthening Australia’s Chemical Regulation

Gabriela

Leong

Ong

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…The practices of inequitable regulation, generation, storage, treatment, and disposal of pharmaceutical pollutants is an environmental justice issue that also encourages the exploration of the social determinants of health [ 39 ]. While research on toxic exposures in vulnerable populations often focuses on air pollution, synthetic chemicals released into the environment as pollutants from waste disposal can contribute to global health disparities [ 40 ].…”

Section: Social Determinants Of Health and Environmental Health Dispa...mentioning

confidence: 99%

Comparing Environmental Policies to Reduce Pharmaceutical Pollution and Address Disparities

Desai¹,

Njoku

Nimo-Sefah

2022

IJERPH

View full text Add to dashboard Cite

Pharmaceutical products, including active pharmaceutical ingredients and inactive ingredients such as packaging materials, have raised significant concerns due to their persistent input and potential threats to human and environmental health. Discourse on reducing pharmaceutical waste and subsequent pollution is often limited, as information about the toxicity of pharmaceuticals in humans is yet to be fully established. Nevertheless, there is growing awareness about ecotoxicity, and efforts to curb pharmaceutical pollution in the European Union (EU), United States (US), and Canada have emerged along with waste disposal and treatment procedures, as well as growing concerns about impacts on human and animal health, such as through antimicrobial resistance. Yet, the outcomes of such endeavors are often disparate and involve multiple agencies, organizations, and departments with little evidence of cooperation, collaboration, or oversight. Environmental health disparities occur when communities exposed to a combination of poor environmental quality and social inequities experience more sickness and disease than wealthier, less polluted communities. In this paper, we discuss pharmaceutical environmental pollution in the context of health disparities and examine policies across the US, EU, and Canada in minimizing environmental pollution.

show abstract

Environment Injustice and Public Health

Njoku

Sampson

2023

Handbook of Social Sciences and Global Public Health

View full text Add to dashboard Cite

Synthetic Chemical Trade as a Potential Driver of Global Health Disparities and Data Gaps on Synthetic Chemicals in Vulnerable Populations

Cited by 7 publications

References 52 publications

Strengthening Australia’s Chemical Regulation

Strengthening Australia’s Chemical Regulation

Comparing Environmental Policies to Reduce Pharmaceutical Pollution and Address Disparities

Environment Injustice and Public Health

Contact Info

Product

Resources

About